The last few months have seen the identification of a number of new variants of the SARS-CoV-2 coronavirus.  In this podcast, the NextGen Advisors discuss the status of vaccination campaigns, the implications of these new variants on efforts to control the pandemic and how pharmaceutical companies and researchers are responding to this challenge.